Unknown

Dataset Information

0

Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist.

ABSTRACT: This report describes the discovery of a potent, orally bioavailable CC chemokine receptor 2 (CCR2) antagonist which, while optimized for CCR2 potency, also had potent CC chemokine receptor 5 (CCR5) activity.

SUBMITTER: Pasternak A 

PROVIDER: S-EPMC4007850 | biostudies-other | 2010 Apr

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.
| S-EPMC4018168 | biostudies-literature
Unknown Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity.
| S-EPMC4007949 | biostudies-literature
Unknown Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5.
| S-EPMC4394346 | biostudies-literature
Unknown Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist.
| S-EPMC4018154 | biostudies-literature
Unknown Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist.
| S-EPMC4007836 | biostudies-other
Unknown Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus.
| S-EPMC4867477 | biostudies-literature
Unknown UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.
| S-EPMC4148167 | biostudies-literature
Unknown Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.
| S-EPMC4025788 | biostudies-other
Unknown Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
| S-EPMC4007909 | biostudies-other
Unknown Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist.
| S-EPMC4360146 | biostudies-literature